SCHEMBL1737151

SCHEMBL1737151

Cc1[nH]c2c(N(Cc3ccc(F)cc3)C(=O)OC(C)(C)C)nc(Cl)cc2c1C

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 2/20 0.39
KCNQ4 P56696 3/20 0.36
KCNQ5 Q9NR82 3/20 0.36
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
KDM1A O60341 2/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
MDM2 Q00987 1/20 0.32
BCL2A1 Q16548 1/20 0.32
RIPK1 Q13546 2/20 0.32
POLB P06746 1/20 0.32
GAA P10253 1/20 0.32
NR1D1 P20393 1/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1736959 0.78 CSF1R (0.40)
SCHEMBL3591511 0.77 GRM2 (0.36) GRM2KCNQ4KCNQ5MEN1KMT2A
SCHEMBL1736219 0.77 GNRHR (0.40) GRM2MEN1KMT2A
SCHEMBL3590303 0.74 MEN1 (0.37) GRM2KCNQ4KCNQ5MEN1KMT2A
SCHEMBL1735588 0.74 POLB (0.39) MEN1KMT2APOLBGAALMNA
SCHEMBL1737130 0.73 SSTR4 (0.39) GRM2KCNQ4KCNQ5HDAC8HDAC6
SCHEMBL1736929 0.72 NR1D1 (0.43) GRM2KCNQ4KCNQ5MEN1KMT2A
Hydrochloric Acid SCHEMBL5811975 0.72 SSTR4 (0.38) GRM2KCNQ4KCNQ5HDAC8HDAC6
SCHEMBL6081384 0.71 MAPK14 (0.43) GRM2KCNQ4KCNQ5HDAC8HDAC6
SCHEMBL12253205 0.71 GRM2 (0.39) GRM2KCNQ4KCNQ5MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188114-B2 Pyrrolo[2,3-C]pyridine derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2012-05-29 US disclosed
EP-1784404-B1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORP (KR) 2011-11-16 EP disclosed
US-20110263306-A1 COMPUTER SYSTEM AND PROGRAM NAMCO BANDAI GAMES INC. (JP) 2011-10-27 US disclosed
US-20100069430-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2010-03-18 US disclosed
US-7662832-B2 Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2010-02-16 US disclosed
EP-1784404-A4 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORP (KR) 2009-09-09 EP disclosed
US-20070219230-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2007-09-20 US disclosed
EP-1784404-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF Yuhan Corporation (KR) 2007-05-16 EP disclosed
WO-2006025716-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2006-03-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069430-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF PGA5, ATP6AP1, ATP6V1H GRM2 3507/4885KCNQ4 1293/4885KCNQ5 1191/4885
US-20070219230-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF PGA5, ATP6AP1, ATP6V1H GRM2 3507/4885KCNQ4 1293/4885KCNQ5 1191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.